The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
GoodRx Inc., America’s leading resource for healthcare savings, and Boehringer Ingelheim, a privately owned, leading global biopharmaceutical company,...
read more
MindMed, a biotech company developing psychedelic-inspired therapies, announced the addition of Robert H. Dworkin, Ph.D. to its Scientific Advisory ...
read more
Mustang Bio Inc., a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential ...
read more
The U.S. FDA has approved an expanded label for Eli Lilly and Company's (NYSE: LLY) rapid-acting insulin, Lyumjev® (insulin lispro-aabc injection) 100...
read more
Wednesday, August 18, 2021
Harrow Health Inc, an ophthalmic healthcare company, entered into an agreement with Wakamoto Pharmaceutical Co., Ltd. to acquire the US and Canadian ...
read more
Regeneron Pharmaceuticals Inc. announced that the United Kingdom's (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted ...
read more
Navega Therapeutics is developing a different approach with DNA targeting to treat chronic pain and aid in the opioid epidemic via epigenetic ...
read more
Abveris, Inc. ("Abveris") and Abilita Bio, Inc. ("Abilita"), both privately held biotechnology companies, announce a joint research collaboration that...
read more
BioMarin Pharmaceutical Inc. announced that the European Commission (EC) granted marketing authorization for VOXZOGO® (vosoritide), a once daily ...
read more
SignalRx Pharmaceuticals Inc., Crystec Ltd., and ADYA Consulting SAGL announced a new collaboration to develop an inhaled dry powder formulation of ...
read more
Catalent, Inc., the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and ...
read more
Octapharma USA announced the FDA Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [...
read more
Wednesday, September 01, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the FDA has approved long-acting atypical antipsychotic INVEGA HAFYERA™ (6-month ...
read more
Friday, September 03, 2021
Impel NeuroPharma Inc., a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high ...
read more
Friday, September 03, 2021
The FDA has approved Invega Hafyera (paliperidone palmitate) extended-release injectable suspension to treat schizophrenia in certain adults. Invega ...
read more